TR6-23917-07309

4 vaccinations 6 coded responses 38 check-ins 6 free-text entries 0 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 956 / CA
Registered: 2021-01-17

Relationship: Self
Race: Multiracial
Ethnicity: Not Hispanic or Latino

Registered dependents

C6N-63689-36962 Child or adolescent in my care · Female · 2022-06-21

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-14
Dose 1 — Pfizer-BioNTech
2021-01-17
Registered in v-safe
2021-01-17
Survey response — days 1–6 daily, dose 1
MedDRA: Increased viscosity of upper respiratory secretion, Rhinorrhoea — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Runny nose, thick mucus

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-04
Dose 2 — Pfizer-BioNTech
2021-02-04
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fever · None

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Itching · Fatigue or tiredness, Diarrhea

Adult check-in
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-09
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-13
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-18
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-25
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-04
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-18
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-05-06
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-05
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-27
Dose 3 — Pfizer-BioNTech
2021-09-28
Survey response — days 1–6 daily, dose 3
MedDRA: Increased viscosity of upper respiratory secretion — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Thick mucus

MedDRA releases: 2024-11 · check-in free text available
2021-09-29
Survey response — days 1–6 daily, dose 3
MedDRA: Rhinorrhoea — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2021-09-30
Survey response — days 1–6 daily, dose 3
MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain, Swelling

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Health check-in — day 7, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-10-27
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-08
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2021-12-29
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-03-28
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-06
Dose 4 — Moderna
2022-09-07
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-09-08
Survey response — days 1–6 daily, dose 4
MedDRA: Oedema peripheral — Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Free text: Underarm swelling

MedDRA releases: 2024-11 · check-in free text available
2022-09-09
Survey response — days 1–6 daily, dose 4
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Swollen lymph nodes

MedDRA releases: 2024-11 · check-in free text available
2022-09-10
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-11
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-09-13
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-09-22
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-09-29
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-08
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-20
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-12-06
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2023-03-08
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-14	Pfizer-BioNTech
2	2021-02-04	Pfizer-BioNTech
3	2021-09-27	Pfizer-BioNTech	No
4	2022-09-06	Moderna	No

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-17

Systemic reaction (other): Runny nose, thick mucus

Release 9 — days 1–6 daily, dose 3

2021-09-28

Systemic reaction (other): Thick mucus

2021-09-29

Systemic reaction (other): Runny nose

2021-09-30

Systemic reaction (other): Runny nose

Release 12 — days 1–6 daily, dose 4

2022-09-08

Systemic reaction (other): Underarm swelling

2022-09-09

Systemic reaction (other): Swollen lymph nodes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Increased viscosity of upper respiratory secretion	✓	✓	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Oedema peripheral	·	·	✓
SRO	Rhinorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release